dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Ubicación actual:
>
> This Story


Conexión o Registro to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Women's Health Homepage

Latest ACP mammo guidelines elicit strong opposition Experts say findings could lead to 10,000 more breast cancer deaths annually

Study supports 3D mammography for older women, contrary to USPTSF recommendation New data sheds light on risk-benefit ratio of screening older patients

FDA proposes changes to mammography regulations First agency efforts to 'modernize' breast screening in over two decades

Volpara and GE expand breast density software partnership GE will become global distributor of VolparaDensity software

Not all breast density laws are created equally Research shows that the wording of some notifications result in supplemental testing, others don't

3D mammography helps avoid unnecessary breast biopsies, says study 33 percent difference in biopsy rate compared to standard mammography

New study finds AI breast screening interpretations on par with those of radiologists Could relieve high labor intensity of screening programs

South Dakota passes breast density law Will require all women who undergo mammograms to be notified of their breast density status

FDA warns against thermography alone for breast cancer detection Not a substitute for mammography

Mammography reports nationwide to include patient breast density Federal law takes aim at ensuring breast density awareness

Increased recall rate isn't a concern,
expert says

DBT detects 34 percent more cancers than 2D mammo

por Lauren Dubinsky , Senior Reporter
A Swedish study that screened 15,000 patients over the course of five years found that breast tomosynthesis detects 34 percent more cancers than 2D mammography.

This is one of many recent studies that have demonstrated the benefits of breast tomosynthesis over conventional mammography. This raises the question: is this technology headed toward becoming the standard screening tool?

Story Continues Below Advertisement

RaySafe helps you avoid unnecessary radiation

RaySafe solutions are designed to minimize the need for user interaction, bringing unprecedented simplicity & usability to the X-ray room. We're committed to establishing a radiation safety culture wherever technicians & medical staff encounter radiation.



Dr. Jay Baker, president of the Society of Breast Imaging, told HCB News that although it will happen, it may take another decade. Most insurance companies are now covering the full cost of tomosynthesis in the screening setting and almost all sales of of mammography systems in the U.S. include tomosynthesis capability.

“The rate limiting step at the moment is that the equipment is expensive,” he said. “So as older 2D mammography systems need to be replaced, they will almost certainly be replaced with tomosynthesis systems.”

This new study was conducted by a group of researchers from Lund University and Skåne University Hospital. In addition to increasing the cancer detection rate, they found that tomosynthesis also reduced breast compression, which makes the exam more comfortable for the patient.

The study did find that tomosynthesis was associated with a higher recall rate than conventional mammography, but Baker said that isn’t a cause for concern. He explained that the recall rate is higher in this study because it was conducted in Sweden.

“In Sweden, their baseline callback rate is much lower than it is in the U.S. and Canada,” he added. “Tomosynthesis is simply showing them some of the benign lesions that the European radiologists either weren't attuned to or have been trained to ignore.”

In the U.S., the target is to recall between five percent and 12 percent of women for additional views. In most studies, tomosynthesis has reduced those recalls by 15 percent to 35 percent.

However, recall rates are already well below five percent in Europe. That means that tomosynthesis makes findings that would have been ignored more clear.

The Swedish research team is currently working on a study that is assessing the cost-benefit of tomosynthesis. The team is also working on studies investigating the use of computers to automate parts of the tomosynthesis image review process.

“I do think that breast tomosynthesis will eventually become the standard tool for breast cancer screening, Baker concluded. “As this and other studies show, we can find more breast cancer and often at earlier stages.”

Back to HCB News
  Pages: 1

Women's Health Homepage


You Must Be Logged In To Post A Comment

Anuncie
Aumente su conciencia de marca
Subastas + ventas Privadas
Consigue el mejor precio
Comprar Equipo/Piezas
Encuentra El Precio Más Bajo
Noticias diarias
Lee las últimas noticias
Directorio
Examina todos los usuarios DOTmed
Ética en DOTmed
Ver nuestro programa de ética
El oro parte programa del vendedor
Recibir las solicitudes de PH
Programa de distribuidor con servicio gold
Recibe solicitudes
Proveedores de atención de salud
Ver todos los HCP (abreviatura de asistencia médica) Herramientas
Trabajos/Entrenamiento
Encontrar/rellenar un trabajo
Parts Hunter +EasyPay
Obtener presupuestos para piezas
Certificado recientemente
Ver usuarios certificados recientemente
Recientemente clasificado
Ver usuarios certificados recientemente
Central de alquiler
Alquila equipos por menos
Vende equipos/piezas
Obtén más dinero
Mantenga el foro de los técnicos
Buscar ayuda y asesoramiento
Petición sencilla de propuestas
Obtén presupuestos para equipos
Feria comercial virtual
Encuentra servicio para el equipo
El acceso y el uso de este sitio está conforme a los términos y a las condiciones de nuestro AVISO LEGAL & AVISO DE LA AISLAMIENTO
Característica de y propietario DOTmeda .com, inc. Copyright ©2001-2019 DOTmed.com, Inc.
TODOS LOS DERECHOS RESERVADOS